SJS Investment Consulting’s Insmed INSM Stock Holding History

SJS Investment Consulting’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$960	Buy	9 +2	+29%	+$242	﹤0.01%	2041
2026 Q1	$1.15K	Sell	7 -7	-50%	-$1.08K	﹤0.01%	1421
2025 Q4	$2.44K	Buy	14 +11	+367%	+$2.01K	﹤0.01%	1105
2025 Q3	$433	Hold	3	–	–	﹤0.01%	1277
2025 Q2	$302	Sell	3 -12	-80%	-$918	﹤0.01%	1257
2025 Q1	$1.15K	Sell	15 -2	-12%	-$153	﹤0.01%	956
2024 Q4	$1.17K	Sell	17 -6	-26%	-$432	﹤0.01%	939
2024 Q3	$1.68K	Buy	23 +6	+35%	+$443	﹤0.01%	875
2024 Q2	$1.14K	Buy	17 +4	+31%	+$155	﹤0.01%	974
2024 Q1	$353	Hold	13	–	–	﹤0.01%	1391
2023 Q4	$403	Buy	13 +6	+86%	+$156	﹤0.01%	1311
2023 Q3	$177	Buy	+7	New	+$160	﹤0.01%	1475
2023 Q2	–	Sell	-5	Closed	-$86	–	1614
2023 Q1	$86	Buy	+5	New	+$97	﹤0.01%	1474

Other funds holding INSM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

SJS Investment Consulting's INSM Position: Q2 2026 in Review

SJS Investment Consulting increased its Insmed (INSM) stake by 29% in Q2 2026, buying an estimated $242 and bringing the position to 9 shares worth $960. The position accounts for ﹤0.01% of the portfolio, ranked #2041.

SJS Investment Consulting first reported a position in INSM in Q1 2023 and has held it in 13 quarters since. The position peaked at $2.44K in Q4 2025. 291 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

SJS Investment Consulting held 9 shares of Insmed worth $960 as of Q2 2026.
SJS Investment Consulting bought 2 Insmed shares in Q2 2026, an estimated $242.
Insmed made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2041 holding.
SJS Investment Consulting first reported a position in Insmed in Q1 2023 and has held it in 13 quarters since.
SJS Investment Consulting's Insmed position peaked at $2.44K in Q4 2025.
291 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.